Intensively, DEDDIE continues coordinated and targeted actions to combat the phenomenon of rheumatics, in the last period of time, more than more than 700 checks In businesses in the HORECA industry (hotels, restaurants, cafes), having already identified cases rheumat the value of which exceeds the 1.2 million euros.

More specifically, from the approximately 700 and more checks conducted by DEDDIE’s specialized workshops in the catering and hospitality industry throughout Greece from November 2024 to February 2025, have already been identified, with the completion of the relevant laboratory checks by the cash, with the completion of the relevant laboratory controls by the cash. 131 cases of rheumatopeswith the non -recorded action exceeding 4.8 GWh and with requirements exceeding EUR 1.2 million. At the same time, another 153 cases are in the process of certification of rheumatoid articles through laboratory tests, with the final number of fair rheumatics expected to increase significantly.

It is noteworthy that in some cases of well -known chains of stores, the percentage of a rheumatic rheumatic exceeded 50% of the number of benefits controlled, which demonstrates the potentially systematic nature of the phenomenon in such cases.

It is noted that during the checks, HEDNO proceeded to Replace all cash with smart metersallowing immediate detection of violations. In addition, strict storage and storage protocols were applied. The assistance of the Greek Police was crucial to ensuring the smooth conduct of the audits, providing the necessary support to the workshops where it was deemed necessary, and a corresponding cooperation and necessary support will then be in the context of intensifying the company’s actions to tackle and tackle the phenomenon.

As noted in the announcement, the struggling of phenomenon of rheumatolopes is strategic priority For HEDNO, as it is an illegal behavior that burdens the legal and economically consistent citizens.

In this context, DEDDIE implements a coordinated plan of actions and actions by making regulatory interventions aimed at tightening the framework of controls and penalties, has more than doubled the technical checks (from 20.5 mm on average in the three-year period 2019-2022 to 41.6 mm) and only 20.6 mm) and only 20.6. In previous years, enhancing the ability to detect and prosecute infringements (from 5.3 mm on average in the three-year period 2019-2022 at 22.2 mm in 2024). The value of confirmed rheumatics also more than doubled, from EUR 30 million in 2023 to EUR 62 million in 2024, while the value of the proceeds from the certified rheumatics amounted to EUR 27.1 million in 2024 from approximately EUR 16.4 million on average 2019-2022.

The treatment plan also includes Automated data analysisstrengthening staff with specialized rheumatoid artisters and optimization of control procedures. At the same time, advanced systems and technologies are utilized to detect and prevent such phenomena.